{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:52:19Z","timestamp":1792651939863,"version":"4.5.0"},"reference-count":43,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T00:00:00Z","timestamp":1458172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Loss-of-function mutations of NaV1.7 lead to congenital insensitivity to pain, a rare condition resulting in individuals who are otherwise normal except for the inability to sense pain, making pharmacological inhibition of NaV1.7 a promising therapeutic strategy for the treatment of pain. We characterized a novel mouse model of NaV1.7-mediated pain based on intraplantar injection of the scorpion toxin OD1, which is suitable for rapid in vivo profiling of NaV1.7 inhibitors. Intraplantar injection of OD1 caused spontaneous pain behaviors, which were reversed by co-injection with NaV1.7 inhibitors and significantly reduced in NaV1.7\u2212\/\u2212 mice. To validate the use of the model for profiling NaV1.7 inhibitors, we determined the NaV selectivity and tested the efficacy of the reported NaV1.7 inhibitors GpTx-1, PF-04856264 and CNV1014802 (raxatrigine). GpTx-1 selectively inhibited NaV1.7 and was effective when co-administered with OD1, but lacked efficacy when delivered systemically. PF-04856264 state-dependently and selectively inhibited NaV1.7 and significantly reduced OD1-induced spontaneous pain when delivered locally and systemically. CNV1014802 state-dependently, but non-selectively, inhibited NaV channels and was only effective in the OD1 model when delivered systemically. Our novel model of NaV1.7-mediated pain based on intraplantar injection of OD1 is thus suitable for the rapid in vivo characterization of the analgesic efficacy of NaV1.7 inhibitors.<\/jats:p>","DOI":"10.3390\/toxins8030078","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T11:35:47Z","timestamp":1458214547000},"page":"78","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain"],"prefix":"10.3390","volume":"8","author":[{"given":"Jennifer","family":"Deuis","sequence":"first","affiliation":[{"name":"Centre for Pain Research, Institute for Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia"},{"name":"School of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Wingerd","sequence":"additional","affiliation":[{"name":"Centre for Pain Research, Institute for Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4119-9637","authenticated-orcid":false,"given":"Zoltan","family":"Winter","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology and Department of Anaesthesiology, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Durek","sequence":"additional","affiliation":[{"name":"Centre for Pain Research, Institute for Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6841-4176","authenticated-orcid":false,"given":"Zoltan","family":"Dekan","sequence":"additional","affiliation":[{"name":"Centre for Pain Research, Institute for Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silmara","family":"Sousa","sequence":"additional","affiliation":[{"name":"Centre for Pain Research, Institute for Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology and Department of Anaesthesiology, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology and Department of Anaesthesiology, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Weidner","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology and Department of Anaesthesiology, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Nassar","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, University of Sheffield, Sheffield S10 2TN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Alewood","sequence":"additional","affiliation":[{"name":"Centre for Pain Research, Institute for Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lewis","sequence":"additional","affiliation":[{"name":"Centre for Pain Research, Institute for Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3594-9588","authenticated-orcid":false,"given":"Irina","family":"Vetter","sequence":"additional","affiliation":[{"name":"Centre for Pain Research, Institute for Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia"},{"name":"School of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,3,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/hmg\/ddm160","article-title":"A stop codon mutation in SCN9A causes lack of pain sensation","volume":"16","author":"Ahmad","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4155\/ppa.14.39","article-title":"Inhibitors of voltage-gated sodium channel Nav1.7: Patent applications since 2010","volume":"3","author":"Sun","year":"2014","journal-title":"Pharm. Pat. Anal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0012-1606(90)90356-N","article-title":"Regulation of muscle sodium channel transcripts during development and in response to denervation","volume":"142","author":"Trimmer","year":"1990","journal-title":"Dev. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1073\/pnas.86.20.8170","article-title":"Molecular cloning of a putative tetrodotoxin-resistant rat heart Na+ channel isoform","volume":"86","author":"Rogart","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.090034797","article-title":"Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses","volume":"97","author":"Caldwell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/pr.57.4.4","article-title":"International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/j.bmcl.2014.06.038","article-title":"Recent progress in sodium channel modulators for pain","volume":"24","author":"Bagal","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1021\/jm501765v","article-title":"Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(v)1.7 sodium channel","volume":"58","author":"Murray","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.peptides.2013.03.011","article-title":"Potency optimization of huwentoxin-IV on hNav1.7: A neurotoxin TTX-s sodium-channel antagonist from the venom of the chinese bird-eating spider selenocosmia huwena","volume":"44","author":"Revell","year":"2013","journal-title":"Peptides"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1124\/mol.108.047670","article-title":"ProTx-II, a selective inhibitor of Nav1.7 sodium channels, blocks action potential propagation in nociceptors","volume":"74","author":"Schmalhofer","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2014.12.056","article-title":"Painful peripheral neuropathy and sodium channel mutations","volume":"596","author":"Hoeijmakers","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1474-4422(14)70150-4","article-title":"Sodium channel genes in pain-related disorders: Phenotype-genotype associations and recommendations for clinical use","volume":"13","author":"Waxman","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/mol.106.022970","article-title":"Potent modulation of the voltage-gated sodium channel Nav1.7 by OD1, a toxin from the scorpion odonthobuthus doriae","volume":"70","author":"Maertens","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1021\/cb400012k","article-title":"Chemical engineering and structural and pharmacological characterization of the alpha-scorpion toxin OD1","volume":"8","author":"Durek","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/mol.115.098178","article-title":"Identification and characterization of ProTx-III [mu-TRTX-Tp1a], a new voltage-gated sodium channel inhibitor from venom of the tarantula thrixopelma pruriens","volume":"88","author":"Cardoso","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E2724","DOI":"10.1073\/pnas.1220844110","article-title":"Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels","volume":"110","author":"McCormack","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.pain.2013.05.032","article-title":"An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways","volume":"154","author":"Deuis","year":"2013","journal-title":"Pain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1073\/pnas.1107027108","article-title":"Mu-conotoxins that differentially block sodium channels Nav1.1 through 1.8 identify those responsible for action potentials in sciatic nerve","volume":"108","author":"Wilson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxicon.2013.10.029","article-title":"Two tarantula venom peptides as potent and differential Na(v) channels blockers","volume":"77","author":"Cherki","year":"2014","journal-title":"Toxicon"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4161\/chan.4847","article-title":"MuO conotoxins inhibit Nav channels by interfering with their voltage sensors in domain-2","volume":"1","author":"Leipold","year":"2007","journal-title":"Channels (Austin Tex.)"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.toxicon.2006.09.022","article-title":"Voltage-gated ion channels and gating modifier toxins","volume":"49","author":"Catterall","year":"2007","journal-title":"Toxicon"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/19336950.2015.1120392","article-title":"Modulation of human Nav1.7 channel gating by synthetic alpha-scorpion toxin OD1 and its analogs","volume":"10","author":"Motin","year":"2015","journal-title":"Channels (Austin Tex.)"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Cheng, X., Dib-Hajj, S.D., Tyrrell, L., and Waxman, S.G. (2008). Mutation I136V alters electrophysiological properties of the Na(v)1.7 channel in a family with onset of erythromelalgia in the second decade. Mol. Pain, 4.","DOI":"10.1186\/1744-8069-4-1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ana.21895","article-title":"A sodium channel gene SCN9A polymorphism that increases nociceptor excitability","volume":"66","author":"Estacion","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbrc.2009.09.121","article-title":"Erythromelalgia mutation L823R shifts activation and inactivation of threshold sodium channel nav1.7 to hyperpolarized potentials","volume":"390","author":"Lampert","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Stadler, T., O'Reilly, A.O., and Lampert, A. (2015). Erythromelalgia mutation Q875Estabilizes the activated state of sodium channel Nav1.7. J. Biol. Chem.","DOI":"10.1074\/jbc.M114.605899"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.neuron.2006.10.006","article-title":"SCN9A mutations in paroxysmal extreme pain disorder: Allelic variants underlie distinct channel defects and phenotypes","volume":"52","author":"Fertleman","year":"2006","journal-title":"Neuron"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1113\/jphysiol.2008.154906","article-title":"Paroxysmal extreme pain disorder mutations within the D3\/S4-S5 linker of nav1.7 cause moderate destabilization of fast inactivation","volume":"586","author":"Jarecki","year":"2008","journal-title":"J. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Dib-Hajj, S.D., Estacion, M., Jarecki, B.W., Tyrrell, L., Fischer, T.Z., Lawden, M., Cummins, T.R., and Waxman, S.G. (2008). Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable. Mol. Pain, 4.","DOI":"10.1186\/1744-8069-4-37"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1113\/jphysiol.2002.026559","article-title":"Sensory and electrophysiological properties of guinea-pig sensory neurones expressing Nav 1.7 (PN1) Na+ channel alpha subunit protein","volume":"546","author":"Djouhri","year":"2003","journal-title":"J. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Black, J.A., Frezel, N., Dib-Hajj, S.D., and Waxman, S.G. (2012). Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn. Mol. Pain, 8.","DOI":"10.1186\/1744-8069-8-82"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2006.121483","article-title":"Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons","volume":"579","author":"Rush","year":"2007","journal-title":"J. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/107385840100700208","article-title":"Sodium channels and neurological disease: Insights from SCN8A mutations in the mouse","volume":"7","author":"Meisler","year":"2001","journal-title":"Neuroscientist"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1476-5381.2009.00301.x","article-title":"Actions of veratridine on tetrodotoxin-sensitive voltage-gated Na currents, Nav1.6, in murine vas deferens myocytes","volume":"157","author":"Zhu","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1124\/jpet.110.178475","article-title":"The efficacy of sodium channel blockers to prevent phencyclidine-induced cognitive dysfunction in the rat: Potential for novel treatments for schizophrenia","volume":"338","author":"Large","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eplepsyres.2009.02.018","article-title":"The relationship between sodium channel inhibition and anticonvulsant activity in a model of generalised seizure in the rat","volume":"85","author":"Large","year":"2009","journal-title":"Epilepsy Res."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Stevens, M., Peigneur, S., and Tytgat, J. (2011). Neurotoxins and their binding areas on voltage-gated sodium channels. Front. Pharmacol., 2.","DOI":"10.3389\/fphar.2011.00071"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1016\/j.bmcl.2015.06.033","article-title":"Sustained inhibition of the Nav1.7 sodium channel by engineered dimers of the domain ii binding peptide gptx-1","volume":"25","author":"Murray","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"27247","DOI":"10.1074\/jbc.M201611200","article-title":"Solution structure of mu-conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels","volume":"277","author":"Nielsen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Minett, M.S., Nassar, M.A., Clark, A.K., Passmore, G., Dickenson, A.H., Wang, F., Malcangio, M., and Wood, J.N. (2012). Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat. Commun., 3.","DOI":"10.1038\/ncomms1795"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1021\/acschemneuro.5b00113","article-title":"Activation of kappa opioid receptors in cutaneous nerve endings by conorphin-1, a novel subtype-selective conopeptide, does not mediate peripheral analgesia","volume":"6","author":"Deuis","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nprot.2008.223","article-title":"Phenotyping sensory nerve endings in vitro in the mouse","volume":"4","author":"Zimmermann","year":"2009","journal-title":"Nat. Protoc."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/8\/3\/78\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:20:51Z","timestamp":1760210451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/8\/3\/78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,17]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["toxins8030078"],"URL":"https:\/\/doi.org\/10.3390\/toxins8030078","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,17]]}}}